The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan.
Saved in:
| Title: | The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan. |
|---|---|
| Authors: | Malagola M; Chair of Hematology, Department of Clinical and Experimental Sciences, University of Brescia, Unit of Blood Disease and Stem Cell Transplantation, ASST-Spedali Civili, Brescia, Italy. Electronic address: michelemalagola@yahoo.it., Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy., Bucelli C; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy., Abruzzese E; Division of Hematology, S. Eugenio Hospital, ASL ROMA2, Tor Vergata University, Roma, Italy., Bonifacio M; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area - University of Verona, Italy., Stagno F; Hematology Unit, AOU Policlinico 'G. Martino', University of Messina, Italy., Binotto G; Hematology and Clinical Immunology, Department of Medicine, Padua School of Medicine, Padova, Italy., D'Adda M; Division of Hematology, ASST-Spedali Civili di Brescia, Brescia, Italy., Lunghi M; Division of Hematology, Department of Translation Medicine, University of Eastern Piedmont, Novara, Italy., Crugnola M; Hematology Unit and BMT Center University Hospital of Parma, Italy., Ferrari ML; Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Lunghi F; Hematology and Bone Marrow Transplantation (BMT) Unit, San Raffaele Scientific Institute, Milano, Italy., Castagnetti F; Institute of Hematology 'Seràgnoli' IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy; Department of Medical and Surgical Sciences University of Bologna, Bologna, Italy., Rosti G; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola (FC), Italy., Lemoli RM; Chair of Hematology, Internal Medicine Dpt, University of Genova, Italy; Clinic of Hematology, IRCCS Policlinico San Martino, Genova, Italy., Sancetta R; Hematology Unit, Dell'Angelo Hospital, Venezia-Mestre, Italy., Coppi MR; Haematology and BMT Unit 'Antonio Perrino' Hospital, Brindisi, Italy., Corsetti MT; Hematology Division, Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., De Gobbi M; Hematology and Internal Medicine Division, San Luigi Hospital, Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy., Romano A; IRCCS Regina Elena National Cancer Institute-Roma, Italy., Tiribelli M; Division of Hematology and BMT, Department of Medicine, University of Udine, Udine, Italy., Russo Rossi A; Hematology and Transplants Unit, University of Bari, Bari, Italy., Russo S; Division of Hematology, Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva, Policlinico G Martino, University of Messina, Messina, Italy., Defina M; Hematology Unit, Dipartimento Terapie Cellulari, Ematologia e Medicina di Laboratorio, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy., Farina M; Chair of Hematology, Department of Clinical and Experimental Sciences, University of Brescia, Unit of Blood Disease and Stem Cell Transplantation, ASST-Spedali Civili, Brescia, Italy., Bernardi S; Chair of Hematology, Department of Clinical and Experimental Sciences, University of Brescia, Unit of Blood Disease and Stem Cell Transplantation, ASST-Spedali Civili, Brescia, Italy; CREA Laboratory (Hematological-Research AIL Centre), ASST-Spedali Civili Brescia, Italy., Butturini G; Chair of Hematology, Department of Clinical and Experimental Sciences, University of Brescia, Unit of Blood Disease and Stem Cell Transplantation, ASST-Spedali Civili, Brescia, Italy., Pellizzeri S; Chair of Hematology, Department of Clinical and Experimental Sciences, University of Brescia, Unit of Blood Disease and Stem Cell Transplantation, ASST-Spedali Civili, Brescia, Italy., Roccaro AM; Clinical Trial Center. Translational Research and Phase I Unit, ASST Spedali Civili, Brescia, Italy., Russo D; Chair of Hematology, Department of Clinical and Experimental Sciences, University of Brescia, Unit of Blood Disease and Stem Cell Transplantation, ASST-Spedali Civili, Brescia, Italy. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 May; Vol. 24 (5), pp. 323-331. Date of Electronic Publication: 2024 Jan 25. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2152-2669 |
|---|---|
| DOI: | 10.1016/j.clml.2024.01.008 |
